Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$149,476,775
-$81,203,480 QoQ
Shares Held
2,382,100
-1.5% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
3.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Sep 30, 2025CallValue
$19,526,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $498,063,409 across 7 Medical Devices names. BSX ranks #2 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RCEL |
AVITA Medical, Inc.
|
41,044,895 | $151,866,111 | |
| 2 | BSX |
Boston Scientific Corp
This page
|
2,382,100 | $149,476,775 | |
| 3 | EW |
Edwards Lifesciences Corp
|
1,230,600 | $98,546,448 | |
| 4 | SYK |
Stryker Corp
|
182,500 | $59,967,675 | |
| 5 | NPCE |
NeuroPace Inc
|
2,096,527 | $27,569,330 | |
| 6 | AORT |
Artivion, Inc.
|
151,000 | $5,529,620 | |
| 7 | NSPR |
InspireMD, Inc.
|
3,133,405 | $5,107,450 |
All Filings in BSX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,476,775 | 2,382,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $230,680,255 | 2,419,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,526,000 | 200,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $237,172,559 | 2,429,300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $302,165,812 | 2,813,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $283,795,616 | 2,813,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $282,277,996 | 3,160,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $274,277,400 | 3,273,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $252,053,730 | 3,273,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $224,167,770 | 3,273,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $191,166,108 | 3,306,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $174,599,040 | 3,306,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $182,818,791 | 3,379,900 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $189,613,700 | 3,790,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $180,369,714 | 3,898,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $150,977,286 | 3,898,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $162,851,265 | 4,369,500 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $203,711,855 | 4,599,500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $235,861,704 | 5,552,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $253,119,904 | 5,833,600 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $295,924,856 | 6,920,600 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $10,690,000 | 250,000 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $267,481,190 | 6,920,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $234,501,850 | 6,523,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $185,215,333 | 4,847,300 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $170,188,703 | 4,847,300 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $158,167,399 | 4,847,300 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||